Extracorporeal membrane oxygenation in the treatment of respiratory failure during COVID‑19
Sign Up to like & getrecommendations! Published in 2020 at "Herz"
DOI: 10.1007/s00059-020-04927-x
Abstract: By April 14, 2020, a total of 1,819,465 confirmedCOVID-19caseswith115,103 deaths have been reported across the world. Clinically, the infection of the novel coronavirus mainly affects the respiratory system leading to pneumonia, while the virus may… read more here.
Keywords: heart; treatment; ecmo; extracorporeal membrane ... See more keywords
Physical therapy for the treatment of respiratory issues using Systemic Manual Therapy protocols
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Bodywork and Movement Therapies"
DOI: 10.1016/j.jbmt.2021.02.009
Abstract: Background The emergence of the Coronavirus (COVID-19) pandemic increased the need for an effective treatment for respiratory conditions exponentially. To meet this challenge, we reevaluated the effectiveness of our physical therapy protocols for respiratory conditions.… read more here.
Keywords: physical therapy; treatment; protocol; therapy ... See more keywords
Inhaled fixed-dose combination powders for the treatment of respiratory infections
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Drug Delivery"
DOI: 10.1080/17425247.2021.1886074
Abstract: ABSTRACT Introduction Respiratory infections are a major cause of morbidity and mortality. As an alternative to systemic drug administration, inhaled drug delivery can produce high drug concentrations in the lung tissue to overcome resistant bacteria.… read more here.
Keywords: drug; fixed dose; respiratory infections; treatment respiratory ... See more keywords
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model
Sign Up to like & getrecommendations! Published in 2017 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00211-17
Abstract: ABSTRACT Pulmonary administration of polymyxins is increasingly used for the treatment of respiratory tract infections caused by multidrug-resistant Gram-negative bacteria, such as those in patients with cystic fibrosis. However, there is a lack of pharmacokinetics… read more here.
Keywords: respiratory tract; model; polymyxin; aerosolized polymyxin ... See more keywords
Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives
Sign Up to like & getrecommendations! Published in 2021 at "Vaccines"
DOI: 10.3390/vaccines9020151
Abstract: Respiratorytract infections (RTIs) are frequent and life-threatening diseases, accounting for several millions of deaths worldwide. RTIs implicate microorganisms, including viruses (influenza virus, coronavirus, respiratory syncytial virus (RSV)), bacteria (Pseudomonas aeruginosa, Streptococcus pneumoniae, Staphylococcus aureus and… read more here.
Keywords: therapeutic antibodies; respiratory tract; treatment; antibodies treatment ... See more keywords